Yong‐Joon Lee

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Byeong‐Keuk Kim, Sung‐Jin Hong, Yong‐Joon Lee et al. · The Lancet · 2022 · 285 citations · Full text

Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial

Sung‐Jin Hong, Seung‐Jun Lee, Yongsung Suh et al. · Circulation · 2023 · 121 citations

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease

Sung‐Jin Hong, Yong‐Joon Lee, Seung‐Jun Lee et al. · JAMA · 2023 · 87 citations · Full text

Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea

Sung-Jin Hong, Seung‐Jun Lee, Sang Hyup Lee et al. · The Lancet · 2024 · 63 citations

Percutaneous Coronary Intervention, Superiority Trial, Health Sciences +13

Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling

Seul-Gee Lee, Darae Kim, Jung‐Jae Lee et al. · BMC Medicine · 2022 · 59 citations · Full text